Schedule 13D ownership disclosure

ABVC BIOPHARMA INC

Common Stock, par value $0.001 per share · CUSIP: 00091F304

Event date: 2025-05-13

Filing-level shares
131,159.00
Percent of class
17.4%
  • Eugene JiangReported CIK 0001892728

    Shares: 131,159.00 · Class: 17.4%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001213900-25-050762
Form type
SCHEDULE 13D
Filer
ABVC BIOPHARMA, INC.
CIK
CIK 1173313
Filed
Jun 03, 2025
Reporting period
May 13, 2025
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub